Bicycle Therapeutics
Stock Forecast, Prediction & Price Target
Bicycle Therapeutics (BCYC) stock Price Target by analysts
$34
Potential upside: 374.86%
Bicycle Therapeutics price prediction
What is Bicycle Therapeutics stock analysts` prediction?
Bicycle Therapeutics stock forecast: Based on 3 Wall Street analysts` predicted price targets for Bicycle Therapeutics in the last 3 months, the avarage price target is $34, with a high forecast of $NaN. The average price target represents a 374.86% change from the last price of $7.16.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Bicycle Therapeutics stock Price Target by analysts
Full breakdown of analysts given Bicycle Therapeutics price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Reni Benjamin JMP Securities | 0% 0/1 | 9 months ago | $26 263.12% upside | $15.32 | TheFly | Previous targets (0) |
Jay Olson Oppenheimer | 0% 0/1 | 11 months ago | $48 570.39% upside | $25.32 | StreetInsider | Previous targets (0) |
Kalpit Patel B.Riley Financial | 0% 0/1 | 11 months ago | $28 291.06% upside | $25.32 | StreetInsider | Previous targets (0) |
Swayampakula Ramakanth H.C. Wainwright | 0% 0/1 | about 1 year ago | $55 668.15% upside | $27.02 | StreetInsider | Previous targets (0) |
Edward Tenthoff Piper Sandler | 0% 0/1 | almost 4 years ago | $76 961.45% upside | $48.69 | TheFly | Previous targets (0) |
Anthony Butler Roth Capital | 0% 0/1 | almost 4 years ago | $65 807.82% upside | $48.69 | StreetInsider | Previous targets (0) |
Bicycle Therapeutics Financial Estimates
Bicycle Therapeutics Revenue Estimates
Bicycle Therapeutics EBITDA Estimates
Bicycle Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $11.69M N/A | $14.46M 23.64% | $26.97M 86.51% | Avg: $31.51M Low: $17.71M High: $48.72M avg. 16.81% | Avg: $47.61M Low: $34.90M High: $68.98M avg. 51.08% | Avg: $119.31M Low: $87.46M High: $172.87M avg. 150.61% | Avg: $329.62M Low: $241.64M High: $477.59M avg. 176.26% |
Net Income
% change YoY
| $-66.81M N/A | $-112.71M -68.69% | $-180.66M -60.28% | Avg: $-233.55M Low: $-234.55M High: $-145.21M avg. -29.27% | Avg: $-254.03M Low: $-248.43M High: $-146.28M avg. -8.77% | Avg: $-163.52M Low: $-258.94M High: $-106.77M avg. 35.63% | Avg: $-47.99M Low: $-76.00M High: $-31.34M avg. 70.64% |
EBITDA
% change YoY
| $-65.49M N/A | $-110.89M -69.31% | $-183.4M -65.37% | Avg: $-31.51M Low: $-48.72M High: $-17.71M avg. 82.81% | Avg: $-47.61M Low: $-68.98M High: $-34.90M avg. -51.08% | Avg: $-119.31M Low: $-172.87M High: $-87.46M avg. -150.61% | Avg: $-329.62M Low: $-477.59M High: $-241.64M avg. -176.26% |
EPS
% change YoY
| -$2.67 N/A | -$3.8 -42.32% | -$5.08 -33.68% | Avg: -$5.12 Low: -$6.59 High: -$4.08 avg. -0.74% | Avg: -$5.22 Low: -$6.98 High: -$4.11 avg. -2.04% | Avg: -$4.59 Low: -$7.28 High: -$3 avg. 12.02% | Avg: -$1.35 Low: -$2.14 High: -$0.88 avg. 70.64% |
Operating Expenses
% change YoY
| $77.31M N/A | $131.11M 69.58% | $216.92M 65.44% | Avg: $77.39M Low: $43.51M High: $119.66M avg. -64.32% | Avg: $116.92M Low: $85.71M High: $169.41M avg. 51.08% | Avg: $293.03M Low: $214.81M High: $424.57M avg. 150.61% | Avg: $809.52M Low: $593.44M High: $1.17B avg. 176.26% |
FAQ
What is Bicycle Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 17.05% in 2025-2028.
We have gathered data from 9 analysts. Their low estimate is -234.55M, average is -233.55M and high is -145.21M.
What is Bicycle Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 98.69% in 2025-2028.
We have gathered data from 9 analysts. Their low revenue estimate is $17.71M, average is $31.51M and high is $48.72M.
What is Bicycle Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 19.97% in 2025-2028.
We have gathered data from 9 analysts. Their low earnings per share estimate is -$6.59, average is -$5.12 and high is $-4.08.
What is the best performing analyst?
In the last twelve months 3 analysts have been covering Bicycle Therapeutics stock. The most successful analyst is Reni Benjamin.